Abstract

The increasing applicability of antifungal treatments, the limited range of available drug classes and the emergence of drug resistance in Candida spp. suggest the need for new treatment options. To explore the applicability of C. albicans photoinactivation, we examined nine structurally different imidazoacridinone derivatives as photosensitizing agents. The most effective derivatives showed a >104-fold reduction of viable cell numbers. The fungicidal action of the three most active compounds was compared at different radiant powers(3.5 to 63 mW/cm2), and this analysis indicated that 7 mW/cm2 was the most efficient. The intracellular accumulation of these compounds in fungal cells correlated with the fungicidal activity of all 9 derivatives. The lack of effect of verapamil, an inhibitor targeting Candida ABC efflux pumps, suggests that these imidazoacridinones are not substrates for ABC transporters. Thus, unlike azoles, a major class of antifungals used against Candida, ABC transporter-mediated resistance is unlikely. Electron paramagnetic resonance (EPR)-spin trapping data suggested that the fungicidal light-induced action of these derivatives might depend on the production of superoxide anion. The highest generation rate of superoxide anion was observed for 1330H, 1610H, and 1611. Singlet oxygen production was also detected upon the irradiation of imidazoacridinone derivatives with UV laser light, with a low to moderate yield, depending on the type of compound. Thus, imidazoacridinone derivatives examined in the present study might act via mixed type I/type II photodynamic mechanism. The presented data indicate lack of direct correlation between the structures of studied imidazoacridinones, cell killing ability, and ROS production. However, we showed for the first time that for imidazoacridinones not only intracellular accumulation is necessary prerequisite of lethal photosensitization of C. albicans, but also localization within particular cellular structures. Our findings present IA derivatives as efficient antifungal photosensitizers with a potential to be used in local treatment of Candida infection.

Highlights

  • Due to longer life span and increasing numbers of people with compromised immune systems, the number of fungal infections caused by yeasts has significantly increased in recent years[1]

  • We observed that, beyond the light dose itself, the time of exposure, and the irradiation power is a critical determinant of the effectiveness of antimicrobial photoinactivation

  • We examined the accumulation of the applied imidazoacridinone derivatives in C. albicans strain 10231 using fluorescent microscopy

Read more

Summary

Introduction

Due to longer life span and increasing numbers of people with compromised immune systems, the number of fungal infections caused by yeasts has significantly increased in recent years[1] This phenomenon is related to a dramatic increase in antifungal drug resistance. There has been no reports indicating the in vitro induction of resistance to the action of light-dependent drugs [4,5,6] Due to their short life times, reactive oxygen species act locally. Photoantimicrobials are only active after light treatment, localized skin and soft tissue infections caused by fungi are good targets for PDI. This treatment assures the selectivity and minimization of the side effects

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call